Hyperprogressive Disease Caused by PD-1 Inhibitors for the Treatment of Pan-Cancer.
Shiyun ChenMiaomiao GouHuan YanMengjiao FanYuting PanRunjia FanNiansong QianGuanghai DaiPublished in: Disease markers (2021)
HPD was developed with different rates in a variety of malignant tumor patients treated with PD-1 inhibitors and related to some clinicopathological features and poor prognosis. Tumor markers, especially CA199, might be served as early predictors of HPD.